Sargent Investment Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,663,275
| Closed | -$15M | – | 207 |
|
|
2022
Q1 | $15M | Sell |
3,663,275
-32,200
| -0.9% | -$117K | 3.79% | 5 |
|
|
2021
Q4 | $13.2M | Buy |
3,695,475
+62,225
| +2% | +$218K | 3.01% | 9 |
|
|
2021
Q3 | $13.2M | Buy |
3,633,250
+37,000
| +1% | +$150K | 3.21% | 8 |
|
|
2021
Q2 | $15.7M | Sell |
3,596,250
-3,330
| -0.1% | -$13.6K | 3.74% | 5 |
|
|
2021
Q1 | $14.8M | Buy |
3,599,580
+110,775
| +3% | +$480K | 3.91% | 5 |
|
|
2020
Q4 | $13.9M | Sell |
3,488,805
-236,080
| -6% | -$764K | 4.42% | 3 |
|
|
2020
Q3 | $10.1M | Sell |
3,724,885
-247,680
| -6% | -$685K | 3.66% | 5 |
|
|
2020
Q2 | $10.7M | Sell |
3,972,565
-625,764
| -14% | -$1.75M | 4.02% | 6 |
|
|
2020
Q1 | $10.9M | Buy |
4,598,329
+508,309
| +12% | +$1.73M | 4.99% | 3 |
|
|
2019
Q4 | $19.2M | Buy |
4,090,020
+765,130
| +23% | +$3.13M | 7.05% | 1 |
|
|
2019
Q3 | $11.1M | Buy |
3,324,890
+108,315
| +3% | +$357K | 4.99% | 2 |
|
|
2019
Q2 | $10.6M | Buy |
3,216,575
+31,620
| +1% | +$91.5K | 4.83% | 2 |
|
|
2019
Q1 | $9.65M | Buy |
3,184,955
+88,600
| +3% | +$287K | 4.65% | 3 |
|
|
2018
Q4 | $8.42M | Buy |
+3,096,355
| New | +$10.2M | 5.18% | 1 |
|